Cholesterol lowerling effect of ezetimibe on hypercholesterolemic patients with type2 diabetes.
Not Applicable
Recruiting
- Conditions
- type2 diabetes patients with hypercholesterolemia
- Registration Number
- JPRN-UMIN000002469
- Lead Sponsor
- Department of Metabolic Medicine, Graduate School of Medical Science, Kumamoto University.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1. patients with cerebrovasucular disease (onset within 12 weeks). 2. patients over 500 mg/dl of TG. 3. patients with cardiovascular disease. 4. patients with liver disfunction. 5. patients with renal disfunction. 6. patients who are estimated not to continue this study by serious diseases. 7. patients with familial hypercholesterolemia. 8. secondary hypercholesterolemia. 9. patients with alcholism or medicinal poisoning. 10. medicinal allergy. 11. patients with pregnancy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method